跳至主要内容
临床试验/NCT02050542
NCT02050542已完成不适用

Comparison of Prostate Cancer Detection Rates Obtained With Multiparametric MRI Targeted Transrectal Ultrasound Biopsies and Systematic Transrectal Ultrasound Biopsies.

Assistance Publique - Hôpitaux de Paris12 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2014年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
12
主要终点
Carcinomatous invasion on biopsies samples

研究概览

简要总结

The purpose of the study is to show that 3 targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system, will get no lower rate of cancer detection than those obtained by 12 systematic transrectal ultrasound-guided biopsies of the prostate.

详细描述

The act of current practice evaluated by this research is the act of prostate biopsies : the patient will have to undergo 12 systematized transrectal echography guided biopsies of the prostate and 3 additional biopsies targeted on the suspicious lesion detected with MRI, which are both done in current practice.

  • A first operator is not informed of the location of the target. He will perform a series of 12 systematic transrectal ultrasound-guided biopsies of the prostate.
  • Immediately after the second operator will perform 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system

Act added by the research: Using a fusion of MRI - ultrasound images software system (Koelis ®).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • patient from 45 to 75 years old;
  • Serum level of PSA > 4,0 ng / mL;
  • Multiparametric prostate IRM, performed before inclusion and which confirm the diagnosis of suspected target;
  • No opposition of the patient notified in the medical record
  • patient member in a national insurance scheme.

排除标准

  • Previous prostate biopsy;
  • suspicious digital rectal examination;
  • serum PSA > 20,0 ng / mL;
  • treatment with 5 alpha reductase inhibitor during the last 3 months;
  • untreated urinary infection

研究组 & 干预措施

Targeted biopsies guided by a fusion of MRI and ultrasound

Other

After the 12 systematic biopsies, the same patients will have to undergo 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system

干预措施: systematic biopsies (Procedure)

Targeted biopsies guided by a fusion of MRI and ultrasound

Other

After the 12 systematic biopsies, the same patients will have to undergo 3 additional targeted biopsies on the suspicious image detected by IRM, guided by a fusion of MRI and ultrasound- images with the Koelis ® system

干预措施: Targeted biopsies guided by a fusion of MRI and ultrasound- images (Procedure)

Systematic biopsies

Other

The patients will have to undergo 12 systematic transrectal ultrasound-guided biopsies of the prostate

干预措施: systematic biopsies (Procedure)

Systematic biopsies

Other

The patients will have to undergo 12 systematic transrectal ultrasound-guided biopsies of the prostate

干预措施: Targeted biopsies guided by a fusion of MRI and ultrasound- images (Procedure)

结局指标

主要结局

Carcinomatous invasion on biopsies samples

时间窗: Day 15

The presence of carcinomatous invasion on biopsies samples

次要结局

  • Respective duration of each biopsy protocol(Day 0)
  • Biopsy Gleason score of the detected cancer(Day 15)
  • Tissue length of biopsy invaded by the detected cancer(Day 15)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验

Study of Current Practice Which Compare the Rate of... | 临床试验